Latest headcount
3,100
YoY change
0.0%
Headcount CAGR
+8.7%
Revenue / employee
$393K
Employee count history for Bio-Techne
| Fiscal year | Employees |
|---|---|
| 1995 | 256 |
| 1996 | 270 |
| 1997 | 282 |
| 1998 | 320 |
| 1999 | 352 |
| 2000 | 387 |
| 2001 | 447 |
| 2002 | 460 |
| 2003 | 474 |
| 2004 | 484 |
| 2005 | 489 |
| 2006 | 577 |
| 2007 | 628 |
| 2008 | 666 |
| 2009 | 687 |
| 2010 | 684 |
| 2011 | 763 |
| 2012 | 783 |
| 2013 | 789 |
| 2014 | 967 |
| 2015 | 1,356 |
| 2016 | 1,560 |
| 2017 | 1,800 |
| 2018 | 2,000 |
| 2019 | 2,250 |
| 2020 | 2,300 |
| 2021 | 2,600 |
| 2022 | 3,000 |
| 2023 | 3,050 |
| 2024 | 3,100 |
| 2025 | 3,100 |
Revenue per employee for Bio-Techne
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 1995 | $186K |
| 1996 | $202K |
| 1997 | $216K |
| 1998 | $210K |
| 1999 | $258K |
| 2000 | $268K |
| 2001 | $258K |
| 2002 | $285K |
| 2003 | $306K |
| 2004 | $333K |
| 2005 | $365K |
| 2006 | $351K |
| 2007 | $356K |
| 2008 | $387K |
| 2009 | $384K |
| 2010 | $393K |
| 2011 | $380K |
| 2012 | $402K |
| 2013 | $394K |
| 2014 | $370K |
| 2015 | $334K |
| 2016 | $320K |
| 2017 | $313K |
| 2018 | $321K |
| 2019 | $317K |
| 2020 | $321K |
| 2021 | $358K |
| 2022 | $369K |
| 2023 | $373K |
| 2024 | $374K |
| 2025 | $393K |
Earnings per employee for Bio-Techne
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 1995 | $26.2K |
| 1996 | $31.9K |
| 1997 | $38.7K |
| 1998 | $47.5K |
| 1999 | $47.4K |
| 2000 | $68.7K |
| 2001 | $76.2K |
| 2002 | $59K |
| 2003 | $95.8K |
| 2004 | $109K |
| 2005 | $135K |
| 2006 | $127K |
| 2007 | $136K |
| 2008 | $155K |
| 2009 | $153K |
| 2010 | $160K |
| 2011 | $147K |
| 2012 | $143K |
| 2013 | $143K |
| 2014 | $115K |
| 2015 | $79.5K |
| 2016 | $67K |
| 2017 | $42.9K |
| 2018 | $62.7K |
| 2019 | $42.7K |
| 2020 | $99.7K |
| 2021 | $54K |
| 2022 | $90.7K |
| 2023 | $93.5K |
| 2024 | $54.2K |
| 2025 | $23.7K |
Employee count history for Bio-Techne (TECH)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 20253,1000.0%
- 20243,100+1.6%
- 20233,050+1.7%
- 20223,000+15.4%
- 20212,600+13.0%
- 20202,300+2.2%
- 20192,250+12.5%
- 20182,000+11.1%
- 20171,800+15.4%
- 20161,560+15.0%
- 20151,356+40.2%
- 2014967+22.6%
- 2013789+0.8%
- 2012783+2.6%
- 2011763+11.5%
- 2010684-0.4%
- 2009687+3.2%
- 2008666+6.1%
- 2007628+8.8%
- 2006577+18.0%
- 2005489+1.0%
- 2004484+2.1%
- 2003474+3.0%
- 2002460+2.9%
- 2001447+15.5%
- 2000387+9.9%
- 1999352+10.0%
- 1998320+13.5%
- 1997282+4.4%
- 1996270+5.5%
- 1995256—
About Bio-Techne's employee count
Bio-Techne (TECH) employed 3,100 people in fiscal year 2025, based on its most recent annual report. That headcount was unchanged from 3,100 a year earlier.
Across the 1995–2025 period, the company's reported workforce went from 256 to 3,100 employees — a compound annual growth rate (CAGR) of +8.7% per year.
Bio-Techne generated about $393K of revenue and $23.7K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on TECH
Employees — 10 rounds, every one of them TECH against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.23% TTM
- Dividend Profile0.44% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.